Publication | Open Access

Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window

Post-ischemic Brain InjuryExtended Therapeutic WindowMedicineEpigenetic ChangeCell DeathNeuropharmacologyBrain InjuryNeuroprotectionNeurologyNeuroimmunologyReperfusion InjuryPharmacologyCell BiologyEpigeneticsIschemic SyndromeEpigenetic DrugsNeuroinflammation